Add to ORKGLiver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis
Chelation therapy with new drugs prevents cardiac damage and improves the survival of thalassemia pa...
Iron overload may still occur in transfusion-independent patients with \u3b2-thalassemia intermedia ...
Patients with thalassemia are often exposed to several risk factors for developing hepatocellular ca...
Iron overload and hepatitis virus C infection cause liver fibrosis in thalassemics. In a monocentric...
Iron overload and hepatitis virus C infection cause liver fibrosis in thalassemics. In a monocentric...
BACKGROUND AND OBJECTIVES: Updated information on liver disease in transfusion-dependent beta-thalas...
A substantial proportion of patients with transfusion-dependent beta-thalassemia major suffer from c...
Iron overload due to increased intestinal iron absorption represents an important clinical problem i...
Abstract Iron overload and hepatitis virus C infection cause liver fibrosis in thalassemics. In a...
Chelation therapy with new drugs prevents cardiac damage and improves the survival of thalassemia pa...
Chelation therapy with new drugs prevents cardiac damage and improves the survival of thalassemia pa...
Survival in patients with transfusion-dependent thalassemias (TDT) has increased, and complications ...
Chelation therapy with new drugs prevents cardiac damage and improves the survival of thalassemia pa...
Survival in patients with transfusion-dependent thalassemias (TDT) has increased, and complications ...
Abstract Iron overload and hepatitis virus C infection cause liver fibrosis in thalassemics. In a m...
Chelation therapy with new drugs prevents cardiac damage and improves the survival of thalassemia pa...
Iron overload may still occur in transfusion-independent patients with \u3b2-thalassemia intermedia ...
Patients with thalassemia are often exposed to several risk factors for developing hepatocellular ca...
Iron overload and hepatitis virus C infection cause liver fibrosis in thalassemics. In a monocentric...
Iron overload and hepatitis virus C infection cause liver fibrosis in thalassemics. In a monocentric...
BACKGROUND AND OBJECTIVES: Updated information on liver disease in transfusion-dependent beta-thalas...
A substantial proportion of patients with transfusion-dependent beta-thalassemia major suffer from c...
Iron overload due to increased intestinal iron absorption represents an important clinical problem i...
Abstract Iron overload and hepatitis virus C infection cause liver fibrosis in thalassemics. In a...
Chelation therapy with new drugs prevents cardiac damage and improves the survival of thalassemia pa...
Chelation therapy with new drugs prevents cardiac damage and improves the survival of thalassemia pa...
Survival in patients with transfusion-dependent thalassemias (TDT) has increased, and complications ...
Chelation therapy with new drugs prevents cardiac damage and improves the survival of thalassemia pa...
Survival in patients with transfusion-dependent thalassemias (TDT) has increased, and complications ...
Abstract Iron overload and hepatitis virus C infection cause liver fibrosis in thalassemics. In a m...
Chelation therapy with new drugs prevents cardiac damage and improves the survival of thalassemia pa...
Iron overload may still occur in transfusion-independent patients with \u3b2-thalassemia intermedia ...
Patients with thalassemia are often exposed to several risk factors for developing hepatocellular ca...